← Open Payments lookup

SARA LEMMON: Open Payments

NPI 1942672647 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,825 in 143 payments from 17 companies in 2025. Trend: 2023 $672 · 2024 $1,741 · 2025 $2,825

Food & beverage: $2,825
CompanyPaymentsAmount
ABBVIE INC.21$375
Vanda Pharmaceuticals Inc.17$367
Otsuka America Pharmaceutical, Inc.14$289
Axsome Therapeutics, Inc.10$267
Neurocrine BioSciences, Inc.11$224
Alkermes, Inc.11$196
Lundbeck LLC9$187
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$155
Indivior Inc.6$147
Takeda Pharmaceuticals U.S.A., Inc.10$136

Products named: REXULTI, VRAYLAR, HETLIOZ, Auvelity, INGREZZA, CAPLYTA, SUBLOCADE, TRINTELLIX.

Industry payments across MD — which companies pay providers there.